Proxima Bio, Inc. — Form D/A
Proxima Bio, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2026-06-10. The offering totals $91.5M, of which $91.5M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2026-06-10
- Form: D/A
- Accession: 0002104665-26-000003
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $91.5M
- Amount sold: $91.5M
- Minimum investment: $1
- Investors: 11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-570576
Issuer
- Name: Proxima Bio, Inc.
- CIK: 0002104665
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 116 E 16TH STREET FLOOR 12, NEW YORK, NY, 10003
- Phone: 212-516-8509
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Zachary Carpenter | Related Person | New York, NY |
| Alex Gasner | Related Person | New York, NY |
| John McFarland | Related Person | New York, NY |
| Jason Pontin | Related Person | New York, NY |
| Jason Pontin | Director | New York, NY |
| Evan Schwartz | Director | New York, NY |
| Zachary Carpenter | Director | New York, NY |
| Zachary Carpenter | Executive Officer | New York, NY |
| John McFarland | Executive Officer | New York, NY |
| Alex Gasner | Director | New York, NY |
Other filings by this issuer (1)
More